Jaka jest cena za BioNxt Solutions Inc. (BNXT)

Cena za BioNxt Solutions Inc. (BNXT) wynosi $0.25320823

Jaka jest kapitalizacja rynkowa dla BioNxt Solutions Inc. (BNXT)

Kapitalizacja rynkowa dla BioNxt Solutions Inc. (BNXT) wynosi $32.92M

BioNxt Solutions Inc. (BNXT) Podziały Akcji

Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.

Rok	Podział	Mnożnik	Skumulowany mnożnik
Za mało danych dla podanych dat.

Rok

Podział

Mnożnik

Skumulowany mnożnik

Za mało danych dla podanych dat.

Firma	Liczba podziałów akcji	Skumulowany mnożnik	Kraj
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

Firma

Liczba podziałów akcji

Skumulowany mnożnik

Kraj